Celemics

Celemics Operating Cash Flow

The Operating Cash Flow of Celemics (331920.KQ) as of Nov 4, 2026 is -3.60 B KRW. In the previous year, Operating Cash Flow was -380.19 M KRW — a change of 846.13% (lower).

Operating Cash Flow

-3.60 BKRW

YoY

846.13%

Last updated:

Operating Cash Flow of Celemics is 2025 -3.60 B KRW. Operating Cash Flow of Celemics was 2024 -380.19 M KRW. It decreases by 846.13% lower compared to the previous year.

The Celemics Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2018
-5.34 B KRW
Jan 1, 2019
-5.37 B KRW
Jan 1, 2020
-4.55 B KRW
Jan 1, 2021
-3.20 B KRW
Jan 1, 2022
-4.15 B KRW
Jan 1, 2023
-4.53 B KRW
Jan 1, 2024
-380.19 M KRW
Jan 1, 2025
-3.60 B KRW
The Celemics Operating Cash Flow history
YEAROperating Cash FlowYoY
-3.60 BKRW+846.13%
-380.19 MKRW-91.61%
-4.53 BKRW+9.25%
-4.15 BKRW+29.65%
-3.20 BKRW-29.70%
-4.55 BKRW-15.17%
-5.37 BKRW+0.58%
-5.34 BKRW+43.32%
-3.72 BKRW-1.55%
-3.78 BKRW+52.69%
-2.48 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Celemics Stock analysis

What does Celemics do? Celemics Inc is a South Korean company based in Seoul, operating within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company provides biotechnology services, focusing on the development and sale of target capture kit products. It also offers immune repertoire analysis solutions and next-generation sequencing solutions. Celemics Inc went public through an IPO on August 21, 2020, and currently employs 63 full-time staff. The company's products are sold in both domestic and international markets. Its headquarters are located in Seoul, South Korea, and it maintains a website at www.celemics.com. The firm's primary business activities include the provision of specialized biotechnology services, with an emphasis on innovative tools and solutions for life science research and applications. Celemics Inc has a presence in the Korean market and extends its reach to global customers, supporting various research and diagnostic needs through its technology-driven services. The company's operational focus remains on developing and delivering advanced biotechnology solutions to meet the evolving demands of the life sciences industry. Celemics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Celemics stock

Operating Cash Flow of Celemics is -3.60 B KRW in 2025.

Operating Cash Flow of Celemics changed from -380.19 M KRW to -3.60 B KRW, representing a 846.13% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Celemics since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Celemics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Celemics

All Key Metrics — Celemics